Immune Therapeutics
Noreen Griffin is an accomplished entrepreneur with extensive experience in the pharmaceutical and consulting industries. Currently serving as Founder and Vice President at Biostax Corp. and Executive Vice President and Founder of Immune Therapeutics Inc., Noreen Griffin has played a pivotal role in developing treatments for chronic diseases through innovative immunotherapy. Prior experience includes leadership roles at Biostax, Inc. and a notable tenure as Chief Executive Officer of Immune Therapeutics from 2012 to 2019. Noreen Griffin also led Griffin Enterprises Group LLC, providing expertise in bankruptcy and corporate communication. Despite incomplete college education, Noreen Griffin has leveraged diverse experiences to build successful business ventures.
This person is not in any teams
Immune Therapeutics
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing, distribution and marketing of our novel patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system.